O7.3 * BET-bromodomain (BRD) inhibitor OTX015: Final results of the dose-finding part of a phase I study in hematologic malignancies
Herait, P., Dombret, H., Thieblemont, C., Facon, T., Stathis, A., Cunningham, D., Palumbo, A., Vey, N., Michallet, M., Recher, C., Rezai, K., Preudhomme, C.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv085.3
Date:
March, 2015
File:
PDF, 31 KB
english, 2015